Mesirow Financial Investment Management’s Walt Disney DIS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.5M Buy
223,189
+4,093
+2% +$417K 0.34% 72
2026
Q1
$21.1M Buy
219,096
+15,801
+8% +$1.67M 0.34% 73
2025
Q4
$23.1M Sell
203,295
-19,310
-9% -$2.13M 0.48% 56
2025
Q3
$25.5M Sell
222,605
-2,391
-1% -$282K 0.46% 55
2025
Q2
$27.9M Sell
224,996
-1,000
-0.4% -$104K 0.54% 47
2025
Q1
$22.3M Sell
225,996
-384
-0.2% -$41.3K 0.43% 55
2024
Q4
$25.2M Buy
226,380
+463
+0.2% +$48.6K 0.5% 47
2024
Q3
$21.7M Sell
225,917
-246
-0.1% -$22.6K 0.42% 58
2024
Q2
$22.5M Buy
226,163
+304
+0.1% +$32.7K 0.51% 51
2024
Q1
$27.6M Buy
225,859
+17,584
+8% +$1.84M 0.63% 42
2023
Q4
$3.06M Buy
+208,275
New +$18.4M 0.11% 119

Other funds holding DIS

Mesirow Financial Investment Management's DIS Position: Q2 2026 in Review

Mesirow Financial Investment Management increased its Walt Disney (DIS) stake by 1.9% in Q2 2026, buying an estimated $417K and bringing the position to 223,189 shares worth $21.5M. The position accounts for 0.34% of the portfolio, ranked #72.

Mesirow Financial Investment Management first reported a position in DIS in Q4 2023 and has held it in 11 quarters since. The position peaked at $27.9M in Q2 2025. 1,365 funds tracked by Wall St. Rank hold DIS as of Q2 2026.

  • Mesirow Financial Investment Management held 223,189 shares of Walt Disney worth $21.5M as of Q2 2026.
  • Mesirow Financial Investment Management bought 4,093 Walt Disney shares in Q2 2026, an estimated $417K.
  • Walt Disney made up 0.34% of Mesirow Financial Investment Management's portfolio in Q2 2026, its #72 holding.
  • Mesirow Financial Investment Management first reported a position in Walt Disney in Q4 2023 and has held it in 11 quarters since.
  • Mesirow Financial Investment Management's Walt Disney position peaked at $27.9M in Q2 2025.
  • 1,365 funds tracked by Wall St. Rank held Walt Disney as of Q2 2026.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.